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Infectious Bursal Disease Virus: Strains That Differ in
Virulence Differentially Modulate the Innate Immune
Response to Infection in the Chicken Bursa
IBRAHIM ELDAGHAYES,1,4 LISA ROTHWELL,1,4 ANDREW WILLIAMS,1,2
DAVID WITHERS,1,3 SUCHARITHA BALU,1 FRED DAVISON,1 and PETE KAISER1
ABSTRACT
Little is understood about the immune responses involved in the pathogenesis of infectious bursal dis-
ease virus (IBDV). Strains of IBDV differ in their virulence: F52/70 is a classical virulent strain (vIBDV),
whereas UK661 is a very virulent strain (vvIBDV) that causes greater pathology and earlier mortality.
The exact causes of clinical disease and death are still unclear. Pro-inflammatory cytokines such as in-
terleukin (IL)-1 and IL-6, produced by activated macrophages, could play a role, as could cytokines
produced by T and natural killer (NK) cells, such as interferon (IFN)-, which stimulate macrophages.
We quantified mRNA transcription in bursal tissue, by real-time quantitative reverse transcrip-
tion–polymerase chain reaction (RT-PCR), for the type I IFN (IFN- and IFN-), pro-inflamma-
tory cytokines (IL-1, IL-6, and CXCLi2), the anti-inflammatory cytokine transforming growth fac-
tor (TGF)-4, and Th1 cytokines (IFN-, IL-2 [and the closely related IL-15], IL-12, and IL-18) for
the first 5 days after infection of 3-week-old chickens with F52/70 or UK661 and compared these
with levels in bursal tissue from uninfected age-matched controls.
Both strains induced a pro-inflammatory response, evidenced by increased mRNA transcription
of IL-1, IL-6, and CXCLi2, and down-regulation of TGF-4, of similar magnitude and timing.
IFN- mRNA was induced by both strains, although to a greater degree by the vvIBDV strain, in-
dicating that a cell-mediated response is induced. Neither virus initially induced high levels of type
I IFN. F52/70 seems to use a “stealth” approach by not inducing the type I IFNs, whereas UK661
down-regulates their expression. This suggests that both viruses modulate the host immune response,
although probably by using different mechanisms.
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INTRODUCTION
INFECTIOUS BURSAL DISEASE VIRUS (IBDV), a smallnonenveloped member of the family Birnaviridae, is
a bisegmented, double-stranded RNA virus encoding
only five proteins (20). Serotype 1 IBDV are highly in-
fectious and cause chronic immunosuppression, morbid-
ity in the form of infectious bursal disease (IBD), and in
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some cases mortality in chickens. A range of serotype 1
pathotypes have been reported, which are classified in in-
creasing order of virulence as mild, intermediate, inter-
mediate plus, classical virulent, very virulent or hyper-
virulent, and, in North America, variant strains (31). Over
the past two decades, Europe and Asia have seen the
emergence of very virulent IBDV (vvIBDV).
IBDV replicates mainly in actively dividing B lym-
phocytes and thereby causing their destruction, primarily
in the bursa of Fabricius but also in the spleen and other
lymphoid tissues. The acute phase usually lasts no more
than 1 week. Virulent strains of IBDV (vIBDV) rarely
cause clinical disease in commercial chicks younger than
2 weeks of age but merely a sustained immunosuppres-
sion. However, in older chicks, vIBDV can cause an acute
disease (19) characterized by extensive lymphoid pathol-
ogy, morbidity, and frequently death (26,31). In surviv-
ing birds the virus is cleared, bursal follicles become re-
populated, and some degree of immunocompetence can
return (14,5,36). However, the recovered chickens usually
have immunosuppression (36) because of the loss of the
developing B cell population in the bursa of Fabricius and
a severely diminished antibody repertoire.
Infection with vvIBDV, unlike classical vIBDV strains
such as F52/70, can break vaccine protection and high
titers of maternally derived antibody, resulting in high
rates of mortality in young birds (1,7). The pathological
changes caused by infection with vvIBDV and the im-
mune responses evoked are less well understood. van den
Berg (31) suggested that vvIBDV causes similar disease
signs to those of classical vIBDV, with the same incu-
bation time of 4 days but an exacerbated acute phase.
This may be the case in chicks with maternal antibodies
against IBDV; but in those lacking maternal antibodies,
clinical IBD developed more rapidly and with greater
severity (35). Immunohistochemical and flow cytometric
analyses of bursa, spleen, and thymus after infection with
the vvIBDV strain UK661 revealed discrete distinctions
compared to vIBDV. Lymphocytes expressing the B-cell
marker Bu-1 and immunoglobulin (Ig)M or IgG were
all depleted from the bursa, spleen, and thymus, sug-
gesting loss of both immature and mature B lymphocytes.
Interestingly, small numbers of Bu-1 cells repopulated
the bursa after 14 days post-infection (dpi); but few of
these expressed IgM or IgG (34).
The mechanisms underlying the pathology caused by
vIBDV and those relating to immune clearance of the virus
have begun to be elucidated. However, little is understood
about the role of cytokines. All immune cells can produce
cytokines, and therefore each has the potential to influence
responses to IBDV. Pro-inflammatory cytokines such as
IL-1 and IL-6, produced by activated macrophages, could
play a role. However, there may also be a role for cytokines
produced by T and natural killer (NK) cells, such as in-
terferon- (IFN-), that stimulate macrophages.
ELDAGHAYES ET AL.
Kim et al. (13) showed that splenic macrophages en-
hanced expression of type I IFN, chicken myelomono-
cytic growth factor (MGF, incorrectly described as a
chicken homologue of IL-6), and IL-8 after vIBDV in-
fection. Ragland et al. (23) reported that vIBDV infec-
tion suppresses transcription of both IFN- and IFN- in
peripheral blood lymphocytes. By contrast, IFN- ex-
pression was increased in the bursa of Fabricius after in-
fection with vIBDV from 2–5 dpi (24).
We have developed a panel of real-time quantitative re-
verse transcription–polymerase chain reaction (RT-PCR)
assays to quantify the expression of a wide variety of
chicken cytokines and chemokines (10,11,12,16,17,22,28).
These include the type I IFNs, the pro-inflammatory 
cytokines IL-1, IL-6, and CXCLi2 (we recently proposed
a new nomenclature for the chicken chemokines (9), and
CXCLi2 was previously known as IL-8); the Th1 cytokines
IL-2 (and the closely related IL-15), IL-12, IL-12, 
IL-18 and IFN-, and the anti-inflammatory cytokine
TGF-4. In this study, we assessed the production of these
cytokines in the bursa of Fabricius during the course of in-
fection with both the benchmark vIBDV strain, F52/70,
and the benchmark vvIBDV strain, UK661. The aim was
to determine which cytokines are produced at the main site
of infection, to provide an indication of the type or types
of immune response induced, and also to test the hypoth-
esis that strains of IBDV with differing virulence induce
different cytokine profiles during the course of infection.
MATERIALS AND METHODS
Chickens. Rhode Island Red (RIR) chicks were ob-
tained from an unvaccinated flock maintained in isola-
tion accommodation at the Institute for Animal Health
(Compton, U.K.). The parents were confirmed to be free
of antibodies to IBDV, chicken infectious anemia virus,
Marek’s disease virus, reovirus and a number of other
pathogens, so the chicks used in these experiments were
deemed to be free of maternal antibodies against IBDV.
The experiments met with local ethical guidelines as well
as those of the U.K. Home Office.
Virus. The vIBDV strain F52/70 (6) and the very vir-
ulent IBDV isolate UK661 (3) were used. The titers of
both virus stocks were kindly determined by Dr. Adriaan
van Loon (Intervet BV, Boxmeer, The Netherlands) as
previously described (32). Based on earlier studies using
these virus stocks, the following doses of 101.7 EID50
vIBDV strain F52/70 and 101.3 EID50 vvIBDV strain
UK661 were selected to cause the same degree of clini-
cal disease and bursal damage, measured as the bursal le-
sion score in RIR chicks 2–3 weeks of age (27,35).
Experimental design. At 3 weeks of age, chicks were
selected at random and placed into two groups designated
as the infected group and the control group. Because of
84
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TABLE 1. REAL-TIME QUANTITATIVE RT-PCR PROBES AND PRIMERS
RNA Accession Exon
Target Probe/primer sequence no.a boundaries
28S Probe (FAM) -AGGACCGCTACGGACCTCCACCA- (TAMRA) X59733 —
Pb GGCGAAGCCAGAGGAAACT
Pc GACGACCGATTTGCACGTC
IFN- Probe (FAM) -CTCAACCGGATCCACCGCTACACC- (TAMRA) U07868 —
F GACAGCCAACGCCAAAGC
R GTCGCTGCTGTCCAAGCATT
IFN- Probe (FAM) -TTAGCAGCCCACACACTCCAAAACACTG- (TAMRA) X92479 —
F CCTCCAACACCTCTTCAACATG
R TGGCGTGCGGTCAAT
IFN- Probe (FAM) -TGGCCAAGCTCCCGATGAACGA- (TAMRA) Y07922 3/4
F GTGAAGAAGGTGAAAGATATCATGGA
R GCTTTGCGCTGGATTCTCA
Il-1 Probe (FAM) -CCACACTGCAGCTGGAGGAAGCC- (TAMRA) AJ245728 5/6
F GCTCTACATGTCGTGTGTGATGAG
R TGTCGATGTCCCGCATGA
IL-2 Probe (FAM) -ACTGAGACCCAGGAGTGCACCCAGC- (TAMRA) AJ009800 2/3
F TTGGAAAATATCAAGAACAAGATTCATC
R TCCCAGGTAACACTGCAGAGTTT
IL-6 Probe (FAM) -AGGAGAAATGCCTGACGAAGCTCTCCA- (TAMRA) AJ309540 4/5
F GCTCGCCGGCTTCGA
R GGTAGGTCTGAAAGGCGAACAG
IL-12 Probe (FAM) -CCAGCGTCCTCTGCTTCTGCCACCTT- (TAMRA) AY262751 1/2
F TGGCCGCTGCAAACG
R ACCTCTTCAAGGGTGCACTCA
IL-12 Probe (FAM) -CTGAAAAGCTATAAAGAGCCAAGCAAGACGTTCT- (TAMRA) AJ564201 1/2
F TGGGCAAATGATACGGTCAA
R CAGAGTAGTTCTTTGCCTCACATTTT
IL-15 Probe (FAM) -AAGTTGCAAATCTTGCATTTCCATTTTTCCA- (TAMRA) AJ416937 4/5
F TAGGAAGCATGATGTACGGAACAT
R TTTTTGCTGTTGTGGAATTCAACT
IL-18 Probe (FAM) -CCGCGCCTTCAGCAGGGATG- (TAMRA) AJ276026 4/5
F AGGTGAAATCTGGCAGTGGAAT
R ACCTGGACGCTGAATGCAA
CXCLi2 Probe (FAM) -TCTTTACCAGCGTCCTACCTTGCGACA- (TAMRA) AJ009800 1/2
F GCCCTCCTCCTGGTTTCAG
R TGGCACCGCAGCTCATT
TGF-4 Probe (FAM) -ACCCAAAGGTTATATGGCCAACTTCTGCAT- (TAMRA) M31160 6/7
F AGGATCTGCAGTGGAAGTGGAT
R CCCCGGGTTGTGTTGGT
IBDV Probe (FAM) -TCCCCTGAAGATTGCAGGAGCATTTG- (TAMRA) D00869 —
F52/70 F GAGGTGGCCGACCTCAACT
VP2 R AGCCCGGATTATGTCTTTGAAG
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the need for contemporaneous sampling of both control
and infected chickens, infections with the different viruses
were carried out in two separate experiments. In each case,
infected birds were housed together in cages in the same
filtered-air, positive-pressure isolation room. In the first
experiment, birds were infected with 101.7 EID50 strain
F52/70 in a total volume of 100 L by the intranasal route
(50 L per nostril). In the second experiment, birds were
infected with 101.3 EID50 strain UK661 in the same vol-
ume by the same route. Controls were kept together but
in a separate isolation room. Bursal tissue from five in-
fected and three controls was removed into RNALater
(Ambion, Huntington, U.K.) at 24 h post-challenge and
at 12 h intervals for 3 days thereafter. Samples were stored
in RNALater at 70°C until further processing.
Sample processing. Bursal tissue (20–60 mg) was ho-
mogenized and total RNA was then prepared using the
RNeasy mini kit (Qiagen, Crawley, U.K.), following the
manufacturer’s instructions. Purified RNA was eluted in
50 L RNase-free water and stored at 70°C.
Detection and quantification of cytokine mRNA.
Cytokine mRNA levels in infected and control samples
were quantified using a well-described method
(10,11,12,16,17,22,28). IBDV RNA (genome) in infected
and control samples was also quantified. Triplicate sam-
ples were assayed for each experiment, and each sample
was also assayed in triplicate.
Primers and probes were designed using the Primer
Express software program (Applied Biosystems, Foster
City, CA); details are given in Table 1. For all cytokines,
either a primer or probe was designed from the sequence
of the relevant genes to lie across intron:exon boundaries.
All probes were labeled with the fluorescent reporter 
dye 5-carboxyfluorescein (FAM) at the 5 end and the
quencher N, N, N, N-tetramethyl-6-carboxyrhodamine
(TAMRA) at the 3 end.
Real-time quantitative RT-PCR was performed using
the Reverse Transcriptase qPCR Master Mix RT-PCR kit
(Eurogentec, Seraing, Belgium). Amplification and de-
tection of specific products were performed using the
ABI PRISM 7700 Sequence Detection System (Applied
Biosystems) with the following cycle profile: one cycle
of 50°C for 2 min, 60°C for 30 min, and 95°C for 5 min;
and 40 cycles of 94°C for 20 sec and 59°C for 1 min.
Quantification was based on the increased fluorescence
detected based on hydrolysis of the target-specific probes
by the 5-exonuclease activity of the rTth DNA poly-
merase during PCR amplification. The passive reference
dye 6-carboxy-c-rhodamine, which is not involved in am-
plification, was used for normalization of the reporter sig-
nal. Results are expressed in terms of the threshold cy-
cle value (Ct), the cycle at which the change in the
reporter dye passes a significance threshold (Rn).
To account for variation in sampling and RNA prepara-
tion, the Ct values for cytokine-specific product for each
sample were standardized using the Ct value of 28S rRNA
product for the same sample. To normalize RNA levels be-
tween samples within an experiment, the mean Ct value for
28S rRNA-specific product was calculated by pooling val-
ues from all samples in that experiment. Tube-to-tube vari-
ations in 28S rRNA Ct values about the experimental mean
were calculated. The slope of the 28S rRNA log10 dilution
series regression line was used to calculate differences in in-
put total RNA. Using the slopes of the respective cytokine
or IBDV log10 dilution series regression lines, the difference
in input total RNA, as represented by the 28S rRNA, was
then used to adjust cytokine-specific Ct values, as follows:
Corrected Ct value  Ct  (Nt-Ct)* S/S, where Ct 
mean sample Ct, Nt  experimental 28S mean, Ct  mean
28S of sample, S  cytokine / IBDV slope, and S= 28S
slope. Results were then expressed as 40-Ct values.
Statistical analysis. Analysis of mean values between
multiple groups was carried out using one-way analysis
of variance. Where a level of significance was found, a
Tukey test was then conducted on the sample data to de-
termine the relative difference between the means within
each set of data. When there were only two groups of
data, means were compared using a paired Student t test.
RESULTS
Changes in IBDV load in the bursa during the
course of infection. After infection with either vIBDV
F52/70 or vvIBDV UK661, viral load (Fig. 1) increased,
reaching a maximum at 72 h post-infection (hpi) in the
case of F52/70 and 84 hpi in the case of vvIBDV. For
vIBDV F52/70 infection, viral load was constant between
72 and 96 hpi, whereas for vvIBDV UK661 infection, vi-
ral load had decreased by 96 hpi. Viral load in bursal tis-
sue was greater at all time points after infection with
vIBDV F52/70 infection (101.7 EID50) compared to in-
fection with vvIBDV UK661 (101.3 EID50).
IBDV infection induces IFN- expression in the bursa
of Fabricius, which increases during the course of in-
fection. IL-2 mRNA expression was not detectable in bur-
sal tissue from either the infected chicks or the uninfected
controls. IL-15 mRNA expression (data not shown) was es-
sentially unaltered in bursal tissue from infected birds com-
pared to controls. IFN- mRNA expression (Fig. 2) was
up-regulated in bursal tissue from infected chicks compared
to levels in controls, from 36 hpi (UK661) and 48 hpi
(F52/70) for the duration of the experiment. Interestingly,
higher levels of IFN- mRNA were detected for UK661
infection (note different scale) than F52/70 infection. How-
ever, this increased IFN- mRNA expression was not dri-
ven by increased expression of IL-12 or IL-18 mRNA in
bursal tissue, as levels in infected birds were not signifi-
cantly increased above those in controls (data not shown).
However, IL-12 mRNA expression was up-regulated in
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bursal tissue from infected chicks from 48 hpi for the du-
ration of the experiment with both strains of virus (Fig. 2).
IL-12 mRNA expression was not detected in bursal tis-
sue from control birds, and therefore these data are pre-
sented as 40-Ct values and not as fold change.
Changes in pro- and anti-inflammatory cytokine
mRNA levels during the course of infection indicate
an inflammatory response occurs in the bursa of
Fabricius. After infection with both vIBDV F52/70 and
vvIBDV UK661, there was an increase in expression in
bursal tissue of mRNA for the pro-inflammatory cy-
tokines IL-1 and IL-6 and the pro-inflammatory
chemokine CXCLi2 (Fig. 3), indicating that IBDV in-
fection results in an inflammatory response in the bursa.
The magnitude of this response was similar for both
strains of virus. Consistent with this, expression of the
anti-inflammatory cytokine TGF-4 was down-regulated
in bursal tissue from infected birds compared to unin-
fected controls, from 48–60 hpi (Fig. 3), and to a greater
degree after F52/70 infection than UK661 infection.
FIG. 1. Bursal load of infectious bursal disease virus
(IBDV) (40-Ct) at various times after infection with either vir-
ulent (F52/70) or very virulent (UK661) IBDV. hpi  hours
post-infection.
FIG. 2. Quantification of interleukin (IL)-12 and interferon (IFN)- in bursal cells after infectious bursal disease virus
(IBDV) infection, expressed as 40-Ct (IL-12) or fold-change in cytokine mRNA levels in infected birds, compared to those
from age-matched, uninfected controls (IFN-). hpi  hours post-infection. *Statistically significantly different from uninfected
controls at p  0.05.
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Strains of IBDV of different virulence modulate the
immune response in the bursa of Fabricius by either not
inducing or down-regulating type I IFN mRNA expres-
sion. Levels of IFN- mRNA in bursal tissue from birds in-
fected with vIBDV F52/70 did not differ significantly from
levels in uninfected controls for the first 48 hpi. At 60 hpi
there was a small but significant (p  0.05) decrease and
later decreases at 84 and 96 hpi (Fig. 4). There were no sig-
nificant changes in the levels of IFN- after infection with
vIBDV F52/70. After vvIBDV UK661 infection, expression
of both type I IFNs was initially down-regulated but then
returned to background levels. In the case of IFN-, there
was again down-regulation from 84 hpi onward, whereas
for IFN- there was evidence of significant (p  0.05) up-
regulation compared to uninfected controls at 60 and 96 hpi.
DISCUSSION
IBDV infects chickens by the feco-oral route and initially
may replicate in cells of the gut-associated lymphoid tis-
sues (33), although this has yet to be confirmed. IBDV in-
fects bursal B lymphocytes and replication is accompanied
by an influx of CD4 and CD8 T cells (29,14,15), which
are activated and express increased levels of an IL-6–like
factor and nitric oxide–inducing factor (15). Rodenberg et
al. (25) studied changes in populations of lymphocyte sub-
sets within the blood, bursa, spleen, and thymus and found
that although the number of IgM cells in the bursa and
spleen decreased significantly, the relative proportions of
CD4 and CD8 T cells did not change. Immunohisto-
chemical analysis of chicken lymphoid tissue, after infec-
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FIG. 3. Quantification of pro-inflammatory (interleukin [IL]-1, IL-6, and CXCLi2) and anti-inflammatory (transforming
growth factor [TGF]–4) cytokines in bursal cells after infectious bursal disease virus (IBDV) infection, expressed as fold-change
in cytokine mRNA levels in infected birds, when compared to those from age-matched, uninfected controls. hpi  hours post-in-
fection. *Statistically significantly different from uninfected controls at p  0.05.
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tion with vIBDV, has been used to determine the location
of the virus and various leukocyte subsets (21,30,33,36).
These studies all indicated an influx of T cells into the bursa,
some expressing the activation marker CD25 (IL-2R) (15).
Williams and Davison (35) observed a transient influx of
macrophages and an influx in CD3, CD4, or CD8 lym-
phocytes into the bursa after infection with vvIBDV. These
extended perturbations in CD3, CD4 or CD8 popula-
tions in the spleen and thymus suggest that vvIBDV caused
more severe and extensive changes than vIBDV.
The spread of vIBDV and vvIBDV within the bursa is
rapid. By 13 hpi, most bursal follicles are positive for the
virus; and by 16 hpi, a second and pronounced viremia
occurs, with secondary replication in other organs, lead-
ing to clinical signs and sometimes death in chicks 3
weeks or more of age. The exact cause of clinical dis-
ease and death is still unclear.
Here we show that viral load in bursal tissue increased
more (between approximately 100- and 1000-fold)
throughout the course of infection after inoculation with
the vIBDV, F52/70, than with the vvIBDV, UK661. Be-
cause UK661 is much more pathogenic than F52/70, the
infecting doses of the two IBDV strains had been selected
to cause a similar time course of pathogenesis, similar clin-
ical signs, and the same degree of bursal pathology, mea-
sured as bursal lesion score (27,35). Earlier work (34)
clearly showed that an inoculum containing 101.7 EID50
UK661 would have resulted in all chicks reaching clinical
endpoints by 48 hpi. Therefore, in this experiment chicks
were inoculated with 101.7 EID50 vIBDV strain F52/70 but
only 101.3 EID50 vvIBDV strain UK661. These data indi-
cate that a higher bursal viral load for vIBDV is necessary
to achieve the same degree of clinical disease. It would be
useful in the future, however, to compare exactly matched
doses to investigate why vvIBDV causes such a marked
pathology and early mortality.
As expected, IBDV infection caused a pro-inflamma-
tory cytokine response in the bursa, as evidenced (Fig.
3) by the up-regulation of the pro-inflammatory cytokines
IL-1, IL-6, and CXCLi2, and the down-regulation of
the anti-inflammatory cytokine TGF-4. The pro-in-
flammatory cytokines were induced to similar levels in
bursal tissues from birds infected with either virus,
whereas F52/70 infection down-regulated TGF-4 ex-
pression to a greater degree than UK661 infection, al-
though this could be related to the higher infecting dose
and higher level of IBDV in the bursa.
The observed increase in IFN- expression (Fig. 2) in
infected bursae presumably reflects this inflammatory re-
sponse and is consistent with earlier published results
(8,24), again suggesting that cell-mediated responses are
initiated to resolve the infection. The IFN- up-regula-
tion was presumably driven by IL-12, inasmuch as 
IL-12 mRNA was detectable only in bursal tissue from
infected birds, whereas IL-12 mRNA was constitutively
expressed in all bursal tissues and did not increase after
infection with either viral strain. IL-18 (IFN-–inducing
factor) does not seem to play a role, as levels in infected
birds were not significantly increased above those in con-
trols (data not shown). Despite the lower infecting dose
FIG. 4. Quantification of type I interferons (IFNs) in bursal cells after infectious bursal disease virus (IBDV) infection, ex-
pressed as fold-change in cytokine mRNA levels in infected birds, when compared to those from age-matched, uninfected con-
trols. hpi  hours post-infection. *Statistically significantly different from uninfected controls at p  0.05.
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and bursal viral load of vvIBDV, UK661 induced far
greater expression of IFN- than infection with F52/70
(230-fold increase as opposed to a 50-fold increase at
96 hpi), suggesting that UK661 infection induces a
stronger cell-mediated inflammatory response.
The lack of increase in type I IFN mRNA in the bursa
after IBDV infection was unexpected. Gelb et al. (8) re-
ported that both attenuated and pathogenic strains of IBDV
stimulated the production of an antiviral factor, assumed
to be IFN, in the bursa of 4-week-old chicks. Although an-
tiviral activity is usually associated with increased levels
of the type I IFNs (i.e., IFN- and IFN-), there was an
increase in IFN- mRNA only at 60 and 96 hpi (Fig. 4).
However, chicken IFN- also has antiviral activity (18).
Our results suggest that IBDV tends to have down-reg-
ulatory effects on the type I IFN response. It seems that
the two IBDV viruses interfere in the type I response in
different ways (Fig. 4). After infection with F52/70, 
IFN- mRNA is initially not significantly altered from
levels in age-matched uninfected controls, and then lev-
els of IFN- mRNA are down-regulated from 60 hpi. Ex-
pression of IFN- mRNA is not significantly altered from
levels in age-matched uninfected controls at any time af-
ter infection. After UK661 infection, IFN- mRNA is
initially down-regulated until at least 36 hpi from levels
in age-matched uninfected controls. Levels then recover
to those in controls, followed by a second down-regula-
tion from 84 hpi onward. IFN- mRNA again is signif-
icantly down-regulated from levels in age-matched un-
infected controls until at least 36 hpi, but levels thereafter
are either the same as in controls or up-regulated. It is
clear from these results that infection with F52/70 results
initially in the noninduction of type I IFNs, suggestive of
a “stealth” approach that allows viral infection to be es-
tablished. Infection with UK661 initially actively down-
regulates type I IFN expression, suggesting active ma-
nipulation of the host immune response. This could
provide a selective advantage for the vvIBDV strain
UK661. The sequence of both F52/70 and UK661 has
been fully determined (2,4). However, it is not obvious
from the known sequence differences what is responsi-
ble for the observed differential regulation of the type I
IFN response, or which IBDV protein functions as an im-
munomodulator, although VP5, which is expressed in
IBDV-infected cells and is not essential for viral repli-
cation in cell culture (20), may be a candidate.
These results indicate that infection with IBDV in-
duces a pro-inflammatory cytokine response and in-
creases in IFN-. It was clear that despite the lower in-
fective dose of vvIBDV, strain UK661 induced a stronger
IFN- response. This could in turn drive the cytokine
storm or “septic shock syndrome,” suggested by van den
Berg (31) as a potential killing mechanism of vvIBDV,
driving the production of apoptotic mediators such as ni-
tric oxide or tumor necrosis factor– by macrophages.
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